SEC Filings

Filing date	Form	Description	View
03/04/22	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001104659-22-030619.pdf 0001104659-22-030619.rtf 0001104659-22-030619.xls
03/02/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-002174.pdf 0001415889-22-002174.rtf 0001415889-22-002174.xls
03/01/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-002078.pdf 0001415889-22-002078.rtf 0001415889-22-002078.xls
02/28/22	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001558370-22-002373.pdf 0001558370-22-002373.rtf 0001558370-22-002373.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/23/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-026089.pdf 0001104659-22-026089.rtf 0001104659-22-026089.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-001693.pdf 0001415889-22-001693.rtf 0001415889-22-001693.xls
02/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-001695.pdf 0001415889-22-001695.rtf 0001415889-22-001695.xls
02/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-001697.pdf 0001415889-22-001697.rtf 0001415889-22-001697.xls
02/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-001699.pdf 0001415889-22-001699.rtf 0001415889-22-001699.xls
02/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-001701.pdf 0001415889-22-001701.rtf 0001415889-22-001701.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.